VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

Influenza virus DNA vaccine pDNA encoding M2 and NP
Vaccine Information
  • Vaccine Name: Influenza virus DNA vaccine pDNA encoding M2 and NP
  • Target Pathogen: Influenza virus
  • Target Disease: Influenza (flu)
  • Vaccine Ontology ID: VO_0004355
  • Type: DNA vaccine
  • Status: Research
  • Host Species as Laboratory Animal Model: Mouse
  • M2 from Influenza A virus (A/Puerto Rico/8/34(H1N1)) gene engineering:
    • Type: DNA vaccine construction
    • Description: This DNA vaccine used the plasmid vector VR10551 to express highly‑conserved influenza gene M2 (Jimenez et al., 2007).
    • Detailed Gene Information: Click Here.
  • NP from Influenza A virus (A/Puerto Rico/8/34(H1N1)) gene engineering:
    • Type: DNA vaccine construction
    • Description: This DNA vaccine used the plasmid vector VR10551 to express highly‑conserved influenza gene NP (Jimenez et al., 2007).
    • Detailed Gene Information: Click Here.
  • DNA vaccine plasmid:
    • DNA vaccine plasmid name:
    • DNA vaccine plasmid VO ID: VO_0005008
  • Immunization Route: intranasal immunization
Host Response

Mouse Response

  • Vaccine Immune Response Type: VO_0000286
  • Immune Response: For instance, NP + M2 may induce both CD4 and CD8 T-cell responses against both antigens and a humoral immune response against the extracellular domain of M2 which collectively contribute to antiviral immunity (Jimenez et al., 2007)
  • Efficacy: 100% protection from challenge with A/HK/8/68 (H3N2) was provided in mice by Vaxfectin-formulated NP+M2 (Jimenez et al., 2007).
References
Jimenez et al., 2007: Jimenez GS, Planchon R, Wei Q, Rusalov D, Geall A, Enas J, Lalor P, Leamy V, Vahle R, Luke CJ, Rolland A, Kaslow DC, Smith LR. Vaxfectin-formulated influenza DNA vaccines encoding NP and M2 viral proteins protect mice against lethal viral challenge. Human vaccines. 2007; 3(5); 157-164. [PubMed: 17637571].